Cargando…

Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools

BACKGROUND: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shih-Wei, Chan, Leong-Perng, Wang, Ling-Feng, Wu, Che-Wei, Lin, Sheng-Hsuan, Huang, Tzu-Yen, Lee, Ka-Wo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846538/ https://www.ncbi.nlm.nih.gov/pubmed/35167611 http://dx.doi.org/10.1371/journal.pone.0263773

Ejemplares similares

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Endoscopic Surveillance for Metachronous Esophageal Squamous Cell Neoplasms among Head and Neck Cancer Patients
por: Chen, Yi-Hsun, et al.
Publicado: (2020)

Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
por: Wang, Hui-Ching, et al.
Publicado: (2020)

Growth Regulated Oncogene-α Upregulates TNF-α and COX-2 and Activates NOD1/RIPK2 mediated-MAPK Pathway in Head and Neck Squamous Cell Carcinoma
por: Chan, Leong-Perng, et al.
Publicado: (2023)

Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study
por: Wang, Hui-Ching, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience
por: Yeh, Tsung-Jang, et al.
Publicado: (2021)

Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck
por: Hung, Yu-Hsuan, et al.
Publicado: (2018)

Prediction of extranodal extension in head and neck squamous cell carcinoma by CT images using an evolutionary learning model
por: Huang, Tzu-Ting, et al.
Publicado: (2023)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2023)

Cricopharyngeal myotomy for delayed Cricopharyngeal dysfunction after head and neck surgery – case report
por: Sung, An, et al.
Publicado: (2020)

Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies
por: Chaulagain, Chakra P., et al.
Publicado: (2018)

Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2017)

Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma
por: Lo, Ta-Hsuan, et al.
Publicado: (2022)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

p27(Kip1) expression as a prognostic marker for squamous cell carcinoma of the head and neck
por: DE ALMEIDA, MIGUEL REIS, et al.
Publicado: (2015)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma
por: Wang, Fang, et al.
Publicado: (2022)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Hsieh, Ching-Yun, et al.
Publicado: (2023)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Expression of p27Kip1 and E-cadherin in Head and Neck Squamous Cell Carcinoma of Indonesian Patients
por: Auerkari, E.I, et al.
Publicado: (2014)

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells
por: Klaassen, I, et al.
Publicado: (2001)

Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma
por: Wang, Lei, et al.
Publicado: (2021)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Survival outcomes of patients with head and neck squamous cell cancer with hepatitis B virus infection: An analysis from an endemic tertiary center
por: Lai, Cheng‐Lun, et al.
Publicado: (2022)

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck
por: Sun, Yan, et al.
Publicado: (2016)

CYP26A1 Is a Novel Biomarker for Betel Quid-Related Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2020)

Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
por: Lin, Yu-Chin, et al.
Publicado: (2014)

Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development
por: Liu, Yu-Fan, et al.
Publicado: (2016)

TRIM24 Overexpression Is Common in Locally Advanced Head and Neck Squamous Cell Carcinoma and Correlates with Aggressive Malignant Phenotypes
por: Cui, Zhibin, et al.
Publicado: (2013)

miR-204 enhances p27 mRNA stability by targeting Brd4 in head and neck squamous cell carcinoma
por: Wang, Caihua, et al.
Publicado: (2018)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
por: Qin, Yixiao, et al.
Publicado: (2021)

Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
por: Lin, Yu-Chin, et al.
Publicado: (2019)

Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
por: Lin, Yu-Chin, et al.
Publicado: (2019)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gjuhs3utgb52ro7ps9i4t1cr5f